RAPT Therapeutics (RAPT) Current Leases: 2022-2023
Historic Current Leases for Therapeutics (RAPT) over the last 2 years, with Dec 2023 value amounting to $2.4 million.
- Therapeutics' Current Leases rose 5.56% to $2.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.5 million, marking a year-over-year increase of 5.56%. This contributed to the annual value of $2.4 million for FY2023, which is 12.76% up from last year.
- Latest data reveals that Therapeutics reported Current Leases of $2.4 million as of FY2023, which was up 12.76% from $2.2 million recorded in FY2022.
- In the past 5 years, Therapeutics' Current Leases ranged from a high of $2.4 million in FY2023 and a low of $2.2 million during FY2022.
- In the last 2 years, Therapeutics' Current Leases had a median value of $2.3 million in 2022 and averaged $2.3 million.
- Data for Therapeutics' Current Leases shows a peak YoY increased of 12.76% (in 2023) over the last 5 years.
- Therapeutics' Current Leases (Yearly) stood at $2.2 million in 2022, then grew by 12.76% to $2.4 million in 2023.